LLY vs CVS
By Alex · Tickerpine
Eli Lilly and Company vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | CVS |
|---|---|---|
| Price | $1,208.12 | $104.34 |
| Market cap | $1.08T | $133.13B |
| P/E ratio | 42.9 | 45.6 |
| ROE | 107.46% | 3.75% |
| Profit margin | 34.99% | 0.72% |
| Revenue growth | 55.50% | 6.10% |
| Dividend yield | 0.57% | 2.55% |
| Beta | 0.52 | 0.62 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs CVS in plain English
- LLY is the bigger company — about 8.1× the market cap of CVS.
- LLY is cheaper on earnings (P/E 42.9 vs 45.6).
- LLY earns a higher return on equity (107% vs 4%).
- LLY is growing revenue faster (56% vs 6%).
- CVS has the higher dividend yield (2.55% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.